ApprovalTrail

Approval · Notice of Compliance 31728 · 2023

SIMPARICA: Notice of Compliance 31728

Issued September 28, 2023

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
31728
Date
September 28, 2023
Company
Zoetis Canada IncKirkland, Quebec, Canada
Product type
Veterinary
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Additional indication

Products in this notice

BrandDINStatus today
SIMPARICANot yet assigned—

Medicinal ingredients